Nexus Surgical And Medicare Ltd.

BSE: 538874 SECTOR: Finance - Stock Broking  1645   5   0

2.52
-0.13 (-4.91%)
BSE: 18 Oct 4:00 PM

Price Summary

Today's High

₹ 2.52

Today's Low

₹ 2.52

52 Week High

₹ 4.17

52 Week Low

₹ 0

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1.38 Cr.

Advances

0 Cr.

No. of Shares

0.55 Cr.

P/E

0

P/B

81.03

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  0.03

Operating Revenue

1.73 Cr.

Net Profit

-5.3 Cr.

Promoter Holding

18.73 %

EPS (TTM)

₹  -0.19

Sales Growth

-19.03

ROE

-221.96 %

ROCE

-209.8%

Profit Growth

-4652.19 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Income Growth

1 Year-19.03%
3 Year78.47%
5 Year31.98%

Profit Growth

1 Year-4652.19%
3 Year-394.37%
5 Year-304.8%

ROE%

1 Year-221.96%
3 Year-76.76%
5 Year-46.58%

ROCE %

1 Year-209.8%
3 Year-72.51%
5 Year-43.87%

ROA%

-186.357178162094

PEG Ratio

0

PAT Margin (%)

-305.791949200082

EPS Growth(%)

NA

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2021 18.73 0
Jun 2021 18.73 0
Mar 2021 18.73 0
Dec 2020 18.73 0
Sep 2020 25 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Operating Income has grown well for the company over past 3 years: 3 years CAGR 78.4746268328957%.

 Limitations

  • Promoters shareholding is low at 18.73%.
  • Company has a poor Return on Equity (ROE) track record of -76.7637240451719%.
  • The company a poor ROCE track record of -72.5133842333431% since last 3 years.
  • Promoter holding has decreased from 25% to 18.73%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Operating Revenue 2.01 1.35 0 0.38 0.23
Other Income 0 0 0.01 0 0.01
Interest Expended 0 0 0 0 0
Operating Expenses 1.5 1.11 0.29 0.68 0.08
Total Provisions 0 0 0 0 0
Depreciation 0 0 0 0 0
Profit Before Tax 0.51 0.24 -0.29 -0.3 0.15
Tax 0.13 0.06 -0.07 -0.1 0.03
Net Profit 0.38 0.18 -0.22 -0.2 0.13

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Operating Income 0.33 0.3 0.98 2.14 1.73
Other Income 0 0 0.06 0.08 0
Interest 0.01 0.01 0 0 0
Operating Expenses 0.25 0.49 1.36 2.32 1.62
Total Provisions 0 0 0 0 0.04
Exceptional Items 0 0 0 0 -5.35
Profit Before Tax 0.07 -0.19 -0.32 -0.11 -5.28
Tax 0.02 0 0.01 0 0.02
Profit After Tax 0.05 -0.19 -0.33 -0.11 -5.3
Adjusted EPS (Rs.) 0.09 -0.35 -0.6 -0.2 -9.68

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 5.47 5.47 5.47 5.47 5.47
Total Reserves 0.17 0 -0.33 -0.44 -5.73
Borrowings 0.09 0 0 0 0
Other N/C liabilities 0 -0.02 -0.02 -0.01 -0.01
Current liabilities 0.04 0.47 0.44 0.46 0.47
Total Liabilities 5.77 5.92 5.57 5.48 0.2
Assets
Loans 0 0 0 0 0
Net Block 0.03 0.03 0.02 0.02 0.02
Capital WIP 5.35 5.35 5.35 5.35 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Other Loans 0.01 0.01 0.01 0.01 0.04
Other N/C Assets 0 0 0 0 0
Current Assets 0.38 0.53 0.19 0.11 0.14
Total Assets 5.77 5.92 5.57 5.48 0.2
* Other Non-current Liabilities include Net deferred Liabilities

Corporate Actions

Investors Details

PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Promoters 25.00 18.73 18.73 18.73 18.73
mildred mercantile... 18.55 18.55 18.55 18.55 18.55
sanjay kumar 4.02 - - - -
visvanathan 2.25 - - - -
ramasubramanian p 0.09 0.09 0.09 0.09 0.09
venkatramani n 0.09 0.09 0.09 0.09 0.09
PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Investors 75.00 81.27 81.27 81.27 81.27
shyam alcohol and ... - 6.27 - 6.27 6.27
shyam alcohol & ch... - - 6.27 - -
globe capital mark... 2.38 2.38 2.38 2.38 2.38
bhanabhai g parmar 3.51 3.51 3.51 3.51 3.51
a & a capital serv... 2.64 2.64 2.64 2.64 2.64
yadvendra sharma 2.49 2.49 2.49 2.49 2.49
neena jain 2.38 2.38 2.38 2.38 2.38
desh raj singha 1.83 1.83 1.83 1.83 1.83
rajeev kumar singh 1.83 1.83 1.83 1.83 1.83
rajendra bhanushan... 1.83 1.83 1.83 1.83 1.83
ritika chona 1.83 1.83 1.83 1.83 1.83
alpana sharma 1.83 1.83 1.83 1.83 1.83
kawaljeet singh du... 1.83 1.83 1.83 1.83 1.83
nishu finlease pri... 1.82 1.82 1.82 1.82 1.82
ruchee chotra 1.46 1.46 1.46 1.46 1.46
ashok kumar dugar 1.46 1.46 1.46 1.46 1.46
piyush ajmera 1.37 1.37 1.37 1.37 1.37

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Nexus Surgical & Med Stock Price Analysis and Quick Research Report. Is Nexus Surgical & Med an attractive stock to invest in?

The financial services company caters to the financial and investing needs of their client. The broking industry in India comes under this sector and is a highly regulated industry in India. There are various regulations related to licensing, clearing and settlement, all of which affect the working of the company. These companies provide an online and offline services platform related to investing into the stock market, mutual funds, bonds, debentures & other financial instruments in order to achieve the financial goals of the clients.

These companies have to be a depository participant of either CDSL or NSDL. The broking industry also registers itself as a clearing member of NSE and BSE.

Around 2% of India's total population invests in financial assets. The penetration of the mutual fund industry in India is close to 7% (Based on the number of PAN cardholders). This under penetration of the mutual fund industry offers a huge opportunity for the industry to grow. Migration to financial savings, wider distribution and sustainable performance are expected to enable growth in the industry.

Also, increasing financial literacy among investors, digitization and the number of mediums available tend to attract more investors to invest in the financial markets.

To understand the functions of the Nexus Surgical & Med better, you must go through the following points:

Key Financials –

  • Profitability: Profit margin (PAT margin) of the company shows how well a company controls its cost. It is one of the important indicators to show the financial health of the company. Net profit of the company is Rs -5.2958435 Cr and the compounded growth of profit in the past 3 years is -394.367800409513 %. The PAT margin of Nexus Surgical & Med is -305.791949200082 %.

  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Nexus Surgical & Med , the EPS #if( -4651.25184094256 > 0) then "grew" else "declined";# by -4651.25184094256 % YOY. 

 Financial Ratios –

  •  Return on Equity (ROE): The Company has a #if( -221.958729251238 >= 20) then "healthy" elseif( -221.958729251238 < 20 and -221.958729251238 >=10) then "average" else "poor";# ROE track record. The ROE of Nexus Surgical & Med is at -221.958729251238 % for the latest year.

  • P/E Ratio: Relative valuation metrics like the P/E ratio can be used to see if the stock of Nexus Surgical & Med is worth at the current levels at Rs $$PRICE_Y_1$$. The stock is trading at a current P/E ratio of 0 and the average historical P/E for the last 5 years was 0.

  • P/B ratio can be one of the best metrics to value such companies. Currently, Nexus Surgical & Med is trading at a P/B of 81.0289 . The average historical P/B for the last 5 years was -2.84315700434306. This can be compared with the Market price per share in order to know if the stock is undervalued or overvalued.

Brief about Nexus Surgical & Med

X